Chris Young
Head of Takeover Defense for Credit Suisse
- Parses a variety of topics, including poison pills, shareholder relations and defense mechanisms.

Chris Cernich
Director of M&A and Proxy Contest Research for ISS
- Discusses of the effectiveness of hybrid boards.

Steven Davidoff
“The Deal Professor” New York Times
- Discusses a New York Times column where the risks of serving on a public board of directors are questioned.

Paul D. Downs, Esq.
Partner, Jones Day
- Reviews various considerations relating to the implementation of poison pills for public companies.